Page 18 - HPIC-Magazine (Feb-2021)
P. 18

News from Abroad


        FOAM BOOSTERS
        Libra Speciality Chemicals to raise betaines

        capacity in UK




           Libra Speciality Chemicals has
        begun a “multi-million-pound capital
        investment programme” in Irlam, UK,
        to increase capacity of its existing be-
        taine plant from 32-ktpa to 50-ktpa to
        meet growing demand.

           The project will involve setting up
        additional reactors to make the betaine
        intermediate, cocamidopropylamine
        (CAPA) and finished betaine pro-
        ducts besides storage infrastructure.
        The company is also installing new
        technology to produce novel low-salt
        betaines to address shift away from  levels of 1,4-dioxane, ethylene oxide  standard betaines contain about 6%
        sulphates. “Our customers are seeking  and sulphate. SLES is also considered  salt, which causes major issues with

        to formulate handwash, body wash  to be a skin sensitiser that can cause  viscosity control in formulations, limi-
        and hair care products with alter-  the skin to become dry, strip out oils  ting the inclusion levels to about
        native surfactants that give better   in the hair leaving it dry & damaged  2%.,” Libra informed.
        efficacy,” the company said.      and also affect dyed hair.
                                                                               The  company  said  its  new  tech-
           Sulphates, such as sodium laureth   Betaines are well known for ex-  nology will produce betaines with
        sulphate (SLES), are increasingly suf-  cellent detergency and foam boosting  ultra-low salt levels giving formulators
        fering from negative press and increas-  properties and do not suffer from the  great freedom to include betaines at

        ing legislation concerned with residual  problems listed for SLES. “However,  10-12%.
        DERMOCOSMETICS
        BASF to source cosmetic peptides from Korea’s

        Caregen



           BASF has signed a global, exclu-                sation trend. By   mentary technology to the bioactives
        sive supply agreement with Korean                  using  cosmetic   and other cosmetic solutions and in-
        biotechnology company, Caregen, for                products formu-  gredients offered by BASF’s personal
        four cosmetic peptides. with anti-ag-              lated with these   care portfolio.
        ing and anti-pigmentation properties.              peptides as ac-
        BASF plans to launch them for prone-               tive ingredients,   Caregen has acquired more than
        atopic and prone-acneic skins during               consumers can    360 patents for peptide substances
        this year.                        have a choice of products with proven   since its establishment in 2001, and
                                          efficacy,” said Mr. Jeff Huh, Head of   has the highest level of capability in
           “There is robust growth in the   Marketing Personal Care Solutions at   Korea in the field of functional peptide
        dermocosmetics sector globally and   BASF Asia Pacific.             research and development. It ope-
        especially in Asia, as more consum-                                 rates two plants in Gunpo city and a
        ers desire targeted functionality from   Caregen’s highly potent synthetic   plant for mass synthesis of peptides
        cosmetics, in line with the personali-  peptides are expected to be a comple-  in Hwaseong.
        18                                            Home, Personal & Institutional Care India  February 2021
   13   14   15   16   17   18   19   20   21   22   23